EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Recurrent Stroke and Progression of Left Ventricular Thrombus During Apixaban Therapy in a Patient with Severe Ischemic Cardiomyopathy: A Case Report

Alaa Babonji iD, Fatima Ahmad Algethmi, Basmah Salman Almutairi, Afnan Alsulami, Adel F Al-Mrzouki iD

American Journal of Case Reports · 2025

DOI: 10.12659/ajcr.949883 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Case Reports, 2025. Verfasst von Alaa Babonji und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Care Services, King Abdulaziz Medical City, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: Pyridones, Pyrazoles, Thrombosis, Factor Xa Inhibitors. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Left ventricular thrombus (LVT) is a well-defined complication of myocardial infarction and congestive heart failure that has an increased risk of morbidity, mortality, and development of systemic embolism. Vitamin K antagonists, such as warfarin, remain the criterion standard therapy. Although direct oral anticoagulants have been shown to be more effective than warfarin in preventing stroke or systemic embolism in patients with atrial fibrillation, there is insufficient and debatable evidence on their efficacy for the treatment of LVT. CASE REPORT A 62-year-old man with multiple comorbidities and a high risk of thrombosis and bleeding risk had a recurrence of stroke secondary to an increase in LVT size while on apixaban 2.5 mg twice daily for 6 months. It was concluded that the patient experienced treatment failure and therefore was switched to warfarin 5 mg. Upon follow-up, a complete resolution was achieved after 5 months. CONCLUSIONS We report a case of recurrence of ischemic stroke and an increase in the size of LVT during apixaban administration in a patient with severe ischemic cardiomyopathy and advanced chronic kidney disease who successfully achieved a complete resolution when shifted to warfarin. This case report questions the hypothesis on the efficacy of apixaban for patients with high risk of thrombosis and bleeding risk and advanced chronic kidney disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyridonesPyrazolesThrombosisFactor Xa InhibitorsStrokeIschemic StrokeCardiomyopathiesHeart DiseasesMyocardial IschemiaHumansMaleMiddle AgedRecurrenceHeart VentriclesWarfarinDisease ProgressionAnticoagulants

Substanzen

PyridonesapixabanPyrazolesFactor Xa InhibitorsWarfarinAnticoagulants

Autor:innen und Institutionen

  • Pharmaceutical Care Services, King Abdulaziz Medical City, Jeddah, Saudi Arabia.
  • Department of Internal Medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
  • Department of Cardiology, King Abdulaziz Medical City, Jeddah, Saudi Arabia.
  • Department of Preventive Medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
  • Department of Hematology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Hematology, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.

ORCID-Profile: Alaa Babonji, Adel F Al-Mrzouki

Zitieren

APA

Babonji, A., Algethmi, F. A., Almutairi, B. S., Alsulami, A., & Al-Mrzouki, A. F. (2025). Recurrent Stroke and Progression of Left Ventricular Thrombus During Apixaban Therapy in a Patient with Severe Ischemic Cardiomyopathy: A Case Report. American Journal of Case Reports. https://doi.org/10.12659/ajcr.949883

Vancouver

Babonji A, Algethmi FA, Almutairi BS, Alsulami A, Al-Mrzouki AF. Recurrent Stroke and Progression of Left Ventricular Thrombus During Apixaban Therapy in a Patient with Severe Ischemic Cardiomyopathy: A Case Report. American Journal of Case Reports. 2025. doi:10.12659/ajcr.949883

BibTeX
@article{Babonji2025,
  author = {Babonji, Alaa and Algethmi, Fatima Ahmad and Almutairi, Basmah Salman and Alsulami, Afnan and Al-Mrzouki, Adel F},
  title = {Recurrent Stroke and Progression of Left Ventricular Thrombus During Apixaban Therapy in a Patient with Severe Ischemic Cardiomyopathy: A Case Report},
  journal = {American Journal of Case Reports},
  year = {2025},
  doi = {10.12659/ajcr.949883}
}
Kostenlos starten →